
Academic Journal
Q2Frontiers in Nuclear Medicine
About Frontiers in Nuclear Medicine
Frontiers in Nuclear Medicine is a scholarly journal published by Frontiers Media SA. SCImago 2025 lists it in Q2, with an SJR of 0.621 and H-index of 11.
Coverage: 2021-2026. Research categories: Radiology, Nuclear Medicine and Imaging (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-12. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Medical Imaging Techniques and Applications; Radiopharmaceutical Chemistry and Applications; Radiomics and Machine Learning in Medical Imaging; Peptidase Inhibition and Analysis; Medical Imaging and Pathology Studies; Cardiac Imaging and Diagnostics.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Absolute stress myocardial blood flow is reduced in patients with prior cardiac disease despite normal perfusion and ejection fraction on rubidium-82 PET: an Arabian Gulf cohort
Ahmad Alenezi, Masoud Garashi, Layla Ghadenfer, Satish Panchadar et al.
2026-09-29 · DOI: 10.3389/fnume.2026.1957482Quantification in bone SPECT/CT
Jovana Zivanovic, Jules Zhang-Yin
2026-09-01 · DOI: 10.3389/fnume.2026.1941906Artificial intelligence across oncologic theranostics: evidence for patient stratification, dosimetry, and adaptive radiopharmaceutical therapy
Mallareddy Banala, Shabbir Ezuddin, Mark Foley, Russ Kuker et al.
2026-08-27 · DOI: 10.3389/fnume.2026.1935247Dual-domain transformer-based learned primal-dual reconstruction for PET imaging
Anton Adelöw, Hamidreza Rashidykanan, Alessandro Guazzo, Massimiliano Colarieti-Tosti et al.
2026-07-31 · DOI: 10.3389/fnume.2026.1885873MRI-derived T stage predicts nodal positivity on PSMA PET/CT in high-risk primary prostate cancer
Michael Courtney, Robert Whiriskey, Ciaran Johnston, Niall Sheehy et al.
2026-07-29 · DOI: 10.3389/fnume.2026.1854064Case Report: Non-invasive [89Zr]Zr-DFO-trastuzumab positron emission tomography in the multimodal characterisation of platinum-resistant high-grade serous ovarian cancer
Joana do Mar Ferreira Machado, Robert Winzer, Rudi Apolle, Almuth Forberger et al.
2026-07-28 · DOI: 10.3389/fnume.2026.1832138Prognostic value of baseline 18F-FDG PET/CT metabolic parameters in EGFR-mutant lung adenocarcinoma patients treated with EGFR-TKIs
Lei Wang, Zhenpeng Wang, Wei Wu
2026-07-08 · DOI: 10.3389/fnume.2026.1864776Cross-Domain TransNet for sparse-view CT reconstruction
Junling Wang, Chunhua Zou, Hongjie Yang, Peixi Liao et al.
2026-07-06 · DOI: 10.3389/fnume.2026.1711533Case Report: Role of MRI, CT, and 18F-FDG PET/CT in staging and response assessment of pediatric synovial sarcoma
Lorena Picori, Livia Maccio, Linda Meneghello, Carmelo Caldarella et al.
2026-07-02 · DOI: 10.3389/fnume.2026.1870009Long vs. short axial field-of-view PET scanners for brain imaging: a phantom study
Laura Providência, Valentina Turmacu, Philipp Mohr, Chris W. J. van der Weijden et al.
2026-06-19 · DOI: 10.3389/fnume.2026.1856651Driving clinical excellence through a management driven framework for integrating nuclear medicine into hospital ecosystems
Chuangyan Zhai
2026-06-15 · DOI: 10.3389/fnume.2026.1837305Availability, accessibility, and economic feasibility of radionuclide therapies in Africa: a systematic review and quantitative infrastructure analysis
Efrah Ahmed Ibrahim
2026-06-04 · DOI: 10.3389/fnume.2026.1825650Impact of reader experience on the time-saving potential of a novel computer-aided tool for Ann Arbor staging of pediatric hodgkin lymphoma
Iryna Vasyliv, Michael Joseph Barrow, Lucia Baratto, Hyun Gi Kim et al.
2026-06-03 · DOI: 10.3389/fnume.2026.1843299Physiological biodistribution of 18F-fluciclovine PET in the head: as a baseline for interpretation in patients with suspected glioma
Yumi Abe, Ryogo Minamimoto, Naotoshi Fujita, Marina Higashi et al.
2026-06-02 · DOI: 10.3389/fnume.2026.1850254Radiopharmacy services in South African academic hospitals: implications for planning radiopharmacy services in Africa
David Kimani, Beverley Summers, Lerato Mosima
2026-04-29 · DOI: 10.3389/fnume.2026.1822893Prognostic impact of discordant lesions on [18F]FDG and [68Ga]Ga-FAPI-04 PET/CT compared to histological FAP expression in neuroendocrine neoplasms
Tim Jedamzik, Aleksander Kosmala, Stefan Kircher, Marieke Heinrich et al.
2026-04-10 · DOI: 10.3389/fnume.2026.1777541Case Report: Five positive lesions on bilateral adrenal glands detected by a single 68Ga-pentixafor PET/CT
Ze Mao, Lu Zheng, Ranliang Hua, Detao Wu et al.
2026-04-10 · DOI: 10.3389/fnume.2026.1676221PET rapid image reconstruction challenge (PETRIC)
Casper da Costa-Luis, Matthias J. Ehrhardt, Christoph Kolbitsch, Evgueni Ovtchinnikov et al.
2026-03-27 · DOI: 10.3389/fnume.2026.1770002Meta-analysis of efficacy and safety of Yttrium-90 radioembolization (TARE) in the treatment of advanced hepatocellular carcinoma
Hongyin Lin, Quanhui Tan
2026-03-19 · DOI: 10.3389/fnume.2026.1784215Radiobiological evaluation of the therapeutic effect of silver-111 for the ISOLPHARM project
Alberto Arzenton, Aurora Leso, Francesca Rana, Giulia S. Valli et al.
2026-03-12 · DOI: 10.3389/fnume.2026.1773638Reviews
Community Reviews
Version History
October 4, 2026 at 9:12 pm
October 2, 2026